Azure Health Technology Limited trading as VGI Health Technology commences trading on National Stock Exchange
Date Posted – 28 May 2021 The Directors are pleased to announce that the shares of Azure Health Technology Limited trading as VGI Health Technology (the Company or VTL) has commenced trading on the National Stock Exchange (NSX)…
ReNerve and VivaZome Enter Collaboration in Spinal Cord Repair
Date Posted – 25 May 2021 ReNerve Ltd (ReNerve) and VivaZome Therapeutics Pty Ltd (VivaZome) today announced that they have entered a collaboration to combine their leading scaffold and exosome technologies, skills and experience…
Monash University – World #2 launches new Master of Pharmaceutical Science
Date Posted – 25 May 2021 Monash University has launched a new postgraduate degree to address a major skills shortage in the Australian pharmaceutical sector and its allied industries. The Master of Pharmaceutical Science will be offered by…
Rhinomed Rhinoswab Secures European CE Mark
Date Posted – 20 May 2021 Rhinomed Limited (ASX:RNO OTCQB:RHNMF), a leader in wearable nasal and respiratory technology, is pleased to announce it has been advised by Medical Device Safety Service GmbH (MDSS) that an Authorized Representative’s Mandate…
Tax breaks tipped to trigger innovation boom
Dated Posted – 20 May 2021 The country’s innovation giants say tax breaks for profits generated on local intellectual property will nurture high-value, local jobs and foster new companies, despite Australia still offering significantly weaker incentives than countries…
New antimicrobial surface reduces bacteria build-up on medical instruments – Monash University
Date Posted – 20 May 2021 Patient infection from urinary catheters are a global health concern. In a world-first, Monash University researchers have developed a new 3D antimicrobial surface to reduce bacterial build-up. The study saw a reduction…
Silicosis research awarded more than $1.6 million – Hudson Institute of Medical Research and Monash University
Date Posted – 20 May 2021 A deadly and incurable lung disease afflicting Australian tradies could be prevented from progressing and successfully treated, following a multi-million federal funding boost to silicosis research. Hudson Institute of Medical Research and…
Victorian budget invests in the health of Generation Victoria – MCRI
Date Posted – 20 May 2021 The Murdoch Children’s Research Institute (MCRI) welcomes the additional investment from the Victorian Government of $14 million AUD to support its innovative Generation Victoria (GenV) research project. The first project of its kind in Australia, GenV…
Accelagen – A 10 Year Overnight Success Story
Date Posted – 20 May 2021 Accelagen, a Melbourne based Regulatory Affairs, Clinical Research and Development Organisation, has come from humble beginnings and grown into a highly successful, effective and committed Contract Research Organisation (CRO) working with…
Federal Budget 2021 – Welcome Initiatives
Date Posted – 12 May 2021 From our CEO, Jeff Malone GAICD on the new budget… This new budget outlines a number of very welcome initiatives including continued and consistent support for the R&D tax incentive and investment into Biotech…
Snoretox wins MRFF Frontier Grant
Date Posted – 17 May 2021 The Minister for Health has announced that Snoretox has won a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a 1 Million dollar 12 month grant and…
SA accelerates local COVID vaccine development for mutant strains
Date Posted – 13 May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of…
